MDSpire - MDSpire Home
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Dana-Farber

  • October 15, 2026
ASCO 2026 Highlights Panel Discussion
  • October 15, 2026
  1. Harold Burstein, Sara Tolaney, Nancy Lin, Erica Mayer, and Jennifer Ligibel discuss breast cancer research presented at the 2026 ASCO Annual Meeting.
  2. The panel discussion focuses on research presented at the 2026 ASCO Annual Meeting.
  3. The discussion features five physicians: Harold Burstein, Sara Tolaney, Nancy Lin, Erica Mayer, and Jennifer Ligibel.
  4. The panelists include specialists with expertise in breast cancer research.
  5. The provided context does not identify specific studies or findings discussed by the panel.
...more

Dana-Farber

  • October 15, 2026
2026 ASCO Breast Cancer Highlights: SENOMAC
  • October 15, 2026

Objective: Harold Burstein, MD, PhD, and Laura S. Dominici, MD, FACS, discuss SENOMAC trial highlights related to whether some patients with early breast cancer

...more
1 min

Dana-Farber

  • October 15, 2026
2026 ASCO Breast Cancer Highlights: Food Access, Poverty, and MBC
  • October 15, 2026

Objective: Harold Burstein, MD, PhD, and Rachel Freedman, MD, MPH discuss a study on the impact of food access and poverty on patients with metastatic breast ca

...more
1 min

Dana-Farber

  • October 15, 2026
2026 ASCO Breast Cancer Highlights: persevERA
  • October 15, 2026

Objective: The video discusses the persevERA trial and oral SERDs in metastatic breast cancer. Approach: Format: Video discussion featuring Harold Burstein, MD,

...more
1 min

Dana-Farber

  • October 15, 2026
2026 ASCO Breast Cancer Highlights: PANKU-Breast02
  • October 15, 2026

Objective: Harold Burstein, MD, PhD, and Ana C. Garrido-Castro, MD, discuss new results from the PANKU-Breast02 study of izalontamab brengitecan (iza-bren), a d

...more
1 min

Dana-Farber

  • October 15, 2026
2026 ASCO Breast Cancer Highlights: BWEL
  • October 15, 2026

Objective: Harold Burstein, MD, PhD, and Jennifer A. Ligibel, MD, discuss research from the Breast Cancer Weight Loss (BWEL) trial and recommendations concernin

...more
1 min

Dana-Farber

  • October 15, 2026
2026 ASCO Breast Cancer Highlights: HER2CLIMB-05
  • October 15, 2026

Objective: Harold Burstein, MD, PhD, and Adrienne Waks, MD, discuss the HER2CLIMB-05 trial and its relevance to treatment for HER2-positive metastatic breast ca

...more
1 min

Dana-Farber

  • October 15, 2026
2026 ASCO Breast Cancer Highlights: Neo-Healer
  • October 15, 2026

Objective: Harold Burstein, MD, PhD, and Adrienne Waks, MD, discuss the Neo-Healer trial in HER2-positive breast cancer. Interpretation: The supplied material i

...more
1 min

Dana-Farber

  • October 15, 2026
2026 ASCO Breast Cancer Highlights: Triple Negative Breast Cancer
  • October 15, 2026

Objective: Harold Burstein, MD, PhD, and Ana C. Garrido-Castro, MD discuss new antibody-drug conjugate treatment options for first-line triple-negative breast c

...more
1 min

MDSpire News

  • October 15, 2026
Medical Oddities: Alive, but convinced otherwise
  • Teraya Smith
  • October 15, 2026
  • 5 min

Objective: The article examines the objective, findings, and clinical context described in Medical Oddities: Alive, but convinced otherwise. Approach: Cotard’s

...more
2 min

MDSpire News

  • October 15, 2026
Cannabis use may be tied to worse sleep
  • Andrea Surnit
  • October 15, 2026
  • 4 min
  1. In a cohort of 1,266 middle-aged adults, investigators assessed cannabis exposure over 35 years and sleep outcomes during 2020 to 2022.
  2. Each additional cannabis-year was associated with lower sleep percentage, greater sleep fragmentation, and more wakefulness after sleep onset on actigraphy.
  3. Recent cannabis use was associated with poorer objective sleep measures and longer sleep duration than never use; former use was not significantly associated with objective sleep.
  4. Neither recent nor cumulative cannabis exposure was associated with self-reported sleep quality.
  5. The observational study could not establish causation, and the authors called for longitudinal, mechanistic, and randomized studies with long-term follow-up and objective sleep assessments.
...more

MDSpire News

  • October 15, 2026
Vitreous cyst may hide behind chronic floaters
  • Andrea Surnit
  • October 15, 2026
  • 2 min

Objective: To describe a symptomatic free-floating vitreous cyst in a patient with longstanding floaters. Approach: Case: A 51-year-old woman had persistent lef

...more
2 min

MDSpire News

  • October 15, 2026
AI may predict focal GBM recurrence
  • Andrea Surnit
  • October 15, 2026
  • 4 min

Objective: To assess whether AI analysis of intraoperative tissue samples, combined with clinical, radiographic, and molecular characteristics, can predict foca

...more
2 min

Phoenix Children's Medical Connection

  • October 15, 2026
Predicting Neonatal Hypoxia in dTGA/IVS Remains Challenging, Heightens Need for High-Risk Delivery Planning
  • October 15, 2026
  • 7 min

Objective: Assess whether fetal echocardiographic findings can predict neonatal hypoxia or the need for urgent balloon atrial septostomy (BAS) in infants with p

...more

MDSpire News

  • October 15, 2026
Dehydration during exercise may contribute to CRVO
  • Andrea Surnit
  • October 15, 2026
  • 3 min

Objective: To describe a case of mild central retinal vein occlusion (CRVO) occurring after intense exercise and assess possible contributing factors. Approach:

...more
2 min

MDSpire News

  • October 15, 2026
Anticoagulant recalled over life-threatening risk
  • Mouj Hijazi
  • October 15, 2026
  • 3 min

Objective: The article examines the objective, findings, and clinical context described in Anticoagulant recalled over life-threatening risk. Approach: Recall s

...more

MDSpire News

  • October 15, 2026
Prenatal diet tied to colic with eczema
  • Andrea Surnit
  • October 15, 2026
  • 4 min
  1. In a prospective cohort of 1,324 mother-infant pairs, 61 infants (5%) had both colic and eczema by a median age of 6.3 months.
  2. Each 1-point increase in maternal Mediterranean Diet Score was associated with 15% lower adjusted odds of infant colic and eczema together.
  3. Each 1-point increase in maternal Dietary Inflammatory Index was associated with 34% higher adjusted odds of the combined outcome.
  4. Neither dietary score was significantly associated with colic alone or eczema alone, and dairy and egg intake were not significantly associated with any outcome.
  5. The observational study relied on maternal reports, included few infants with both conditions, and cannot establish that prenatal diet causes or prevents colic and eczema.
...more

The Medicine Maker

  • October 15, 2026
Looking Beyond Symptoms in Psychiatric Drug Development
  • October 15, 2026
  • 10 min

Objective: The article examines the objective, findings, and clinical context described in Looking Beyond Symptoms in Psychiatric Drug Development. Approach: In

...more
3 min